True Leaf Begins Trading on OTCQB Under “TRLFF” Symbol

True Leaf Begins Trading on OTCQB Under “TRLFF” Symbol

Vancouver, BC, July 20, 2017 – True Leaf Medicine International Ltd. (the “Company”) (CSE: MJ) (FSE: TLA) (OTCQB: TRLFF) is pleased to announce that its common shares have begun trading on the OTC Market Group’s OTCQB® Venture Market under the ticker symbol “TRLFF”. The Company’s common shares will continue to trade on the Canadian Securities Exchange under the symbol “MJ” and on the Frankfurt Stock Exchange under the symbol “TLA”.
 
The OTCQB® Venture Market gives Canadian companies broad access to the U.S. investment community while maintaining standards that result in improved investor confidence and providing a seamless information flow from the Canadian Securities Exchange to the OTCQB.
 
“In response to growing investor interest in the United States, we have chosen to have True Leaf’s shares trade on the OTCQB instead of the OTC Pink tier, with greater exposure and accessibility to our expanding American and international shareholder base,” stated Darcy Bomford, President and CEO of the Company. “We look forward to further expansion of our shareholder base with this event.”
 
In addition, effective July 13, 2017, the Company received FINRA approval to change its OTC ticker symbol to ticker from “TLFMF” to “TRLFF”.
 
About True Leaf:
 
True Leaf Medicine International Ltd., through its wholly-owned subsidiary ‘True Leaf Pet’, has entered the $104.9 billion global pet care industry with a line of hemp-focused pet chews and supplements marketed through natural pet health and veterinary channels in Canada, the United States, and Europe. The Company has also filed an application under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR) to become a Canadian licensed producer through its ‘True Leaf Medicine’ subsidiary. It has passed through the security screening process of Health Canada’s review and is currently in the final review stage before the ‘pre-licensing inspection’ approval.
 
For more information, please see the Company’s website at www.trueleaf.com.
 
Investor Contact:
Kevin Bottomley
Director and Corporate Relations
kevin@trueleaf.com
M: 778-389-9933
 
Media Contact:
Paul Sullivan
BreakThrough Communications
p.sullivan@breakthroughpr.com
O: 604-685-4742
M: 604-603-7358
 
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS PRESS RELEASE.
 
Forward-Looking Information:
 
This press release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks discussed in the Company’s continuous disclosure filings available under the Company's profile on www.sedar.com. While the Company may elect to, it does not undertake to update this information at any particular time.



Also in Press Releases

True Leaf Announces Initial Closing  of its Regulation A+ Offering
True Leaf Announces Initial Closing of its Regulation A+ Offering

True Leaf Medicine International Ltd. (“True Leaf” or the “Company”) (CSE: MJ) (FSE: TLA) (OTCQB: TRLFF), announces that it has conducted an initial closing of its previously announced Regulation A+ offering for gross proceeds in the amount of C$6.18 million for 8,883,590 shares.

Continue Reading

Media Advisory: True Leaf CEO to attend Lift Cannabis Expo Vancouver 2018
Media Advisory: True Leaf CEO to attend Lift Cannabis Expo Vancouver 2018

Vancouver, BC – True Leaf Medicine International Ltd. (“True Leaf”), the quality of life company for people and their pets, will be at the 2018 Lift Cannabis Expo this weekend, and founder and CEO Darcy Bomford will be available for scheduled and on-the-spot interviews, Friday, January 12, and during the expo on Saturday, January 13, and Sunday, January 14.

Continue Reading

True Leaf Exercises Option to Purchase 40-acre Site in Lumby, B.C. to Build Cannabis Production Facility
True Leaf Exercises Option to Purchase 40-acre Site in Lumby, B.C. to Build Cannabis Production Facility

True Leaf Medicine International Ltd. has exercised its option to purchase 40 acres of land that encompasses its facility in Lumby, B.C. through its wholly owned subsidiary True Leaf Medicine Inc.

Continue Reading